Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The use of non-calcium-based phosphate binders, calcitriol, and vitamin D analogues was also associated with lower odds of ABD (Table 2).

Source: 3. Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Methods: This is a retrospective cross-sectional study.

Source: Abstract.

In total, 216 patients were selected using the simple random sampling method.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Prevalence and Correlates of Adynamic Bone Disease in Patients with Kidney Failure in Singapore

Cross-sectional study · Journal of Clinical Medicine · 2026

Original publication title

Prevalence and Correlates of Adynamic Bone Disease in Patients with Kidney Failure in Singapore

Siew Kit Shuit; Erin Yan Qing Wee; Yuan Kai Teh; Fangxia Chen; Regina Shaoying Lim; Manohar Bairy

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background/Objectives:

The spectrum of chronic kidney disease: mineral and bone disorder (CKD-MBD) is changing and adynamic bone disease (ABD) is now believed to constitute the majority of CKD-MBD in the developed world. However, its prevalence and risk factors are poorly described in the literature. Its diagnosis requires bone biopsy, but biochemical criteria including parathyroid hormone (PTH) levels show good correlation. The aim of this study is to understand the prevalence of ABD in our patients with kidney failure (KF) on hemodialysis (HD), identify the risk factors for its development, and in doing so enable early intervention to modify the risk factors specific to our population.

Methods:

This is a retrospective cross-sectional study. A total of 201 prevalent adult patients on maintenance HD for at least 3 months were recruited. Patients with previous parathyroidectomy were excluded. Relevant data including clinical and biochemical parameters, prescribed dialysate and medications, and clinical outcomes were collected. ABD was diagnosed if any intact PTH (iPTH) level during the study period was <15 pmol/L.

Results:

Of the 201 patients in the study (median age 64.5 years), 35 (17.4%) patients had ABD. In the multivariable logistic regression model, the adjusted odds ratio (OR) of ABD was higher with a higher mean adjusted serum calcium level, while the concurrent use of non-calcium-based binders was associated with lower odds of ABD. Activated vitamin D use was also associated with lower odds of ABD, likely reflecting past occurrence of ABD, prompting a pre-emptive discontinuation of activated vitamin D. Overall, 17% of patients had had fractures without significant association with ABD. The mean PTH level was in the target range (15 to 60 pmol/L) in 41% of the cohort. Cardiovascular complications were not significantly associated with ABD.

Conclusions:

Approximately one in every six HD patients in our care have ABD as diagnosed by the iPTH level. Targeting a lower serum calcium level and using non-calcium-based binders may reduce the occurrence of ABD and will need to be tested in prospective studies.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/Objectives

The spectrum of chronic kidney disease: mineral and bone disorder (CKD-MBD) is changing and adynamic bone disease (ABD) is now believed to constitute the majority of CKD-MBD in the developed world. However, its prevalence and risk factors are poorly described in the literature. Its diagnosis requires bone biopsy, but biochemical criteria including parathyroid hormone (PTH) levels show good correlation. The aim of this study is to understand the prevalence of ABD in our patients with kidney failure (KF) on hemodialysis (HD), identify the risk factors for its development, and in doing so enable early intervention to modify the risk factors specific to our population.

Source: Background/Objectives:

Abstract: Results

Of the 201 patients in the study (median age 64.5 years), 35 (17.4%) patients had ABD. In the multivariable logistic regression model, the adjusted odds ratio (OR) of ABD was higher with a higher mean adjusted serum calcium level, while the concurrent use of non-calcium-based binders was associated with lower odds of ABD. Activated vitamin D use was also associated with lower odds of ABD, likely reflecting past occurrence of ABD, prompting a pre-emptive discontinuation of activated vitamin D. Overall, 17% of patients had had fractures without significant association with ABD. The mean PTH level was in the target range (15 to 60 pmol/L) in 41% of the cohort. Cardiovascular complications were not significantly associated with ABD.

Source: Results:

Abstract: Conclusions

Approximately one in every six HD patients in our care have ABD as diagnosed by the iPTH level. Targeting a lower serum calcium level and using non-calcium-based binders may reduce the occurrence of ABD and will need to be tested in prospective studies.

Source: Conclusions:
Authors’ abstract

Background/Objectives:

The spectrum of chronic kidney disease: mineral and bone disorder (CKD-MBD) is changing and adynamic bone disease (ABD) is now believed to constitute the majority of CKD-MBD in the developed world. However, its prevalence and risk factors are poorly described in the literature. Its diagnosis requires bone biopsy, but biochemical criteria including parathyroid hormone (PTH) levels show good correlation. The aim of this study is to understand the prevalence of ABD in our patients with kidney failure (KF) on hemodialysis (HD), identify the risk factors for its development, and in doing so enable early intervention to modify the risk factors specific to our population.

Methods:

This is a retrospective cross-sectional study. A total of 201 prevalent adult patients on maintenance HD for at least 3 months were recruited. Patients with previous parathyroidectomy were excluded. Relevant data including clinical and biochemical parameters, prescribed dialysate and medications, and clinical outcomes were collected. ABD was diagnosed if any intact PTH (iPTH) level during the study period was <15 pmol/L.

Results:

Of the 201 patients in the study (median age 64.5 years), 35 (17.4%) patients had ABD. In the multivariable logistic regression model, the adjusted odds ratio (OR) of ABD was higher with a higher mean adjusted serum calcium level, while the concurrent use of non-calcium-based binders was associated with lower odds of ABD. Activated vitamin D use was also associated with lower odds of ABD, likely reflecting past occurrence of ABD, prompting a pre-emptive discontinuation of activated vitamin D. Overall, 17% of patients had had fractures without significant association with ABD. The mean PTH level was in the target range (15 to 60 pmol/L) in 41% of the cohort. Cardiovascular complications were not significantly associated with ABD.

Conclusions:

Approximately one in every six HD patients in our care have ABD as diagnosed by the iPTH level. Targeting a lower serum calcium level and using non-calcium-based binders may reduce the occurrence of ABD and will need to be tested in prospective studies.

Publication and source details

Original title: Prevalence and Correlates of Adynamic Bone Disease in Patients with Kidney Failure in Singapore

Siew Kit Shuit; Erin Yan Qing Wee; Yuan Kai Teh; Fangxia Chen; Regina Shaoying Lim; Manohar Bairy

Journal of Clinical Medicine · 2026

* Correspondence: manohar.giliyar.bairy@nhghealth.com.sg© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:32:05.506364+00:00

DOI: 10.3390/jcm15103758 · PMC13207198